Brief: IntegraGen announces CE-IVD marking of miRpredX 31-3p kit

IntegraGen SA

07/09/2017 16:54

Sept 7 (Reuters) - INTEGRAGEN SA  ALINT.PA : 
    * ANNOUNCES CE-IVD MARKING OF MIRPREDX 31-3P KIT 
    * TEST PREDICTS PATIENT RESPONSE TO ANTI-EGFR THERAPY IN RAS 
WILD-TYPE METASTATIC COLORECTAL CANCER 
 
Source text for Eikon:  ID:nBw8RDmNCa  
Further company coverage:  ALINT.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))